ANXA2基因敲除小鼠模型在肺癌转移中的应用
研究用CRISPR/Cas9构建ANXA2基因敲除小鼠模型,并建立LLC尾静脉注射肺转移模型,比较敲除组与野生型组的转移灶数量、荧光强度与生存时间。结果显示敲除组转移灶数量显著增多、荧光强度更强,但敲除组中位生存时间显著长于野生型组,数据库分析提示ANXA2高表达与肺癌患者无病生存及总生存缩短相关。
要点
- ANXA2敲除组转移灶数量为7个,野生型组为1个,敲除组显著增多。
- ANXA2敲除组中位生存43天,野生型组26天,敲除组显著延长(P=0.017)。
- GEPIA2数据库478例肺癌患者中,ANXA2高表达组无病生存与总生存均显著缩短(均P<0.05)。
核心结论
- ANXA2与恶性肿瘤转移密切相关,有望成为恶性肿瘤转移治疗的新靶点。
- 进一步深入研究将有助于推动ANXA2从基础研究向临床应用转化。
研究设计与样本
- 采用CRISPR/Cas9技术构建ANXA2基因敲除小鼠模型,经组织DNA提取后PCR测序和Western blot鉴定基因型与蛋白表达。
- 将成功构建的模型分为ANXA2敲除组与野生型组(WT组),每组各8只小鼠,通过尾静脉注射LLC细胞建立肺转移模型。
- 使用活体成像技术监测转移灶形成,并统计两组小鼠生存率。
- 利用GEPIA2数据库分析478例肺癌患者肿瘤组织与正常组织中ANXA2基因表达,并按表达水平分为高表达组与低表达组。
主要发现
- 设计针对ANXA2第1外显子的小向导RNA序列,显微注射获得16只首建鼠,经同种小鼠杂交最终获得30只纯合后代。
- ANXA2敲除组转移灶数量为7个,WT组为1个,敲除组显著增多;WT组荧光强度强于敲除组(P=0.002)。
- ANXA2敲除组小鼠中位生存时间为43天,WT组为26天,敲除组显著延长(P=0.017)。
- GEPIA2数据库分析显示,肺癌肿瘤组织中ANXA2基因表达水平高于正常组织(P<0.05)。
- ANXA2高表达组患者无病生存时间与总生存时间均显著短于低表达组(均P<0.05),ANXA2表达与肺癌患者预后有关(P=6.4e-14)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: ANXA2 plays a crucial role in cancer metastasis, but its mechanism is not yet fully understood. Therefore, it is necessary to establish an ANXA2 gene knockout mouse model to provide an effective tool for subsequent studies on ANXA2-related mechanisms. Methods: A gene knockout mouse model was constructed using CRISPR/Cas9 technology. The model was validated through tissue DNA extraction followed by polymerase chain reaction (PCR), sequencing, and western blot to confirm ANXA2 genotype and protein expression. The successfully constructed models were divided into a model group and a wild-type (WT) group for the creation of a mouse tail vein injection Lewis lung carcinoma (LLC) metastasis model. Metastatic foci formation was monitored using in vivo imaging technology, and the survival rates of the two groups were compared. Results: An sgRNA sequence targeting the first exon of ANXA2 was designed, and 16 founder mice were obtained through microinjection. Through consanguineous hybridization, 30 homozygous offspring were ultimately acquired. After establishing the strains of the mouse model, mice were divided into the ANXA2 knockout group and the WT group, with 8 mice in each group. An LLC lung metastasis model was established in both groups. Compared with the WT group, the number of metastatic foci was significantly increased in the ANXA2 knockout group (7 vs. 1), and the fluorescence intensity was stronger in the WT group than in the knockout group (P=0.002). Using the GEPIA2 database to analyze ANXA2 gene expression in tumor tissues and normal tissues of lung cancer patients, it was found that ANXA2 expression levels were significantly higher in lung cancer tumor tissues compared to normal tissues (P<0.05). The database included data from 478 lung cancer patients, and patients were stratified into high-expression and low-expression groups based on ANXA2 levels. Compared to the low-expression group, patients in the high-expression group exhibited significantly shorter disease-free survival and overall survival (P<0.05, respectively). The survival time of mice in the ANXA2 knockout group (median survival time, 43 days) was significantly longer compared to the WT group (median survival time, 26 days; P=0.017). Additionally, ANXA2 expression is significantly associated with the prognosis of lung cancer patients (P=6.4e-14). Conclusions: ANXA2 is closely associated with cancer metastasis and holds potential as a new target for metastasis treatment. Further in-depth research will greatly facilitate the transition of ANXA2 from basic research to clinical application. 目的: 建立膜联蛋白A2(ANXA2)基因敲除小鼠模型,为后续ANXA2相关机制研究提供有效工具。 方法: 采用CRISPR/Cas9技术构建基因敲除小鼠模型,获得的模型经过组织DNA提取后进行PCR测序和Western blot检测,鉴定ANXA2基因型和蛋白的表达。成功构建的模型分为ANXA2敲除组与野生型组(WT组),通过小鼠尾静脉注射小鼠肺癌细胞(LLC)制作转移模型,使用活体成像技术对转移灶形成进行监测,并最终统计两组小鼠的生存率。 结果: 设计针对ANXA2第1外显子的小向导RNA序列,利用显微注射技术获得16只首建鼠小鼠。通过同种小鼠杂交技术,最终获得30只纯合后代。品系建成后,小鼠分为ANXA2敲除组与WT组,每组各8只小鼠,分别建立LLC肺转移模型。WT组与ANXA2敲除组相比,转移灶数量显著增多(分别为7和1个),荧光强度强于敲除组(P=0.002)。GEPIA2数据库搜索肺癌患者肿瘤组织与正常组织中ANXA2基因的表达,肺癌肿瘤组织中ANXA2基因的表达水平高于正常组织(P<0.05)。ANXA2高表达与患者的无病生存时间、总生存时间缩短有关(均P<0.05)。ANXA2敲除组小鼠中位生存时间(43 d)相比于WT组小鼠(26 d)长(P=0.017),ANXA2表达与肺癌患者预后有关。 结论: ANXA2与恶性肿瘤转移密切相关,有望成为恶性肿瘤转移治疗新靶点。.
引用
- Song WJ, Zhang F, Wang ZS, et al. [The application of ANXA2 gene knockout mouse models in lung cancer metastasis]. Zhonghua Zhong Liu Za Zhi. 2025. PMID: 40113426. doi:10.3760/cma.j.cn112152-20240705-00277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。